20 results
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... PO (or 400 mg IV ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... Penicilliosis #IDSA
Algorithm for Evaluation and Treatment of Asymptomatic Candiduria
Evidence for disseminated candidiasis, Unstable or neutropenic patient
1. fluconazole
Algorithm for Evaluation ... fluconazole 400-800mg iv ... caspofungin 70 mg iv ... anidulafungin 200mg iv ... #Candiduria #Algorithm
Acute ED Migraine Therapy and Preventative Therapy Algorithm:
Acute migraine
 • IV NS IL bolus then infusion
Preventative Therapy Algorithm ... Acute migraine • IV ... • Ketorolac IV ... Migraine #management #algorithm ... #treatment #prevention
Hypokalemia Evaluation Algorithm

Before evaluating hypokalemia, life threatening complications such as arrhythmias and paralysis should be looked
Hypokalemia Evaluation ... Algorithm Before ... evaluating hypokalemia ... be treated with IV ... Hypokalemia #diagnosis #Algorithm
Adrenal Insufficiency Diagnosis Algorithm - Evaluation of HPA Axis Response to ACTH

Early am cortisol < 3
Insufficiency Diagnosis Algorithm ... - Evaluation of ... is 250 mcg of IV ... after intravenous (IV ... Insufficiency #Diagnosis #Algorithm
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Fatigue and IBD Algorithm ... IBD Pearls: • IDA ... and active IBD: IV ... IV FE formulations ... differentiate IDA
Emergency Management of Hyperkalemia in Adults
Assess Patient - Airway Breathing Circulation Disability Exposure (ABCDE) Approach
 •
Calcium Gluconate IV ... Insulin–Glucose IV ... blood glucose Prevention ... Hyperkalemia #management #algorithm
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... stibogluconate) 20 mg/kg IV ... Leishmaniasis #Prevention
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #Prevention #Treatment